EP
Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ·Healthcare·Biotechnology
$8.14
-5.13%
Mkt Cap $287.26M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (2 analysts)
$17.00
Range $17.00 – $17.00
Implied Upside
+108.8%
Consensus $17.00 vs current $8.14
NASDAQ·Healthcare·Biotechnology
$8.14
-5.13%
Mkt Cap $287.26M
Buy
2
Hold
0
Sell
0
Price Target (2 analysts)
$17.00
Range $17.00 – $17.00
+108.8%
Consensus $17.00 vs current $8.14